Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Neal

Showing results (361-370 of 484) with videos related to

Pageof 49
Sort By:
European Journal of Heart Failure|June 27, 2024
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trialMuthiah Vaduganathan, Christopher P Cannon, Meg J Jardine, et al.
Journal of Hypertension|October 1, 2010
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trialsSébastien Czernichow, Alberto Zanchetti, Fiona Turnbull, et al.
Journal of the American Heart Association|January 8, 2017
Mean Dietary Salt Intake in Urban and Rural Areas in India: A Population Survey of 1395 PersonsClaire Johnson, Sailesh Mohan, Kris Rogers, et al.
Circulation|June 27, 2018
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney FunctionBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
BMJ (Clinical Research Ed.)|April 24, 2020
Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling studyMatti Marklund, Gitanjali Singh, Raquel Greer, et al.
Kidney International|December 14, 2012
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitusMuh Geot Wong, Vlado Perkovic, Mark Woodward, et al.
International Journal of Cardiology|June 23, 2020
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS programClare Arnott, Brendon L Neuen, Hiddo J L Heerspink, et al.
Frontiers in Nutrition|June 29, 2026
Dietary intake and sources of sodium and potassium, and salt-related knowledge, attitudes, and behaviours among rural adults in China: a cross-sectional studyBeike Wu, Jianwei Xu, Zhifang Li, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 14, 2018
Percentage of ingested sodium excreted in 24-hour urine collections: A systematic review and meta-analysisAaron M Lucko, Chelsea Doktorchik, Mark Woodward, et al.
American Heart Journal|June 5, 2017
Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)-A large-scale cluster randomized controlled trialBruce Neal, Maoyi Tian, Nicole Li, et al.
Pageof 49

Showing results (361-370 of 484) with videos related to

Sort By:
Pageof 49
European Journal of Heart Failure|June 27, 2024
Effects of canagliflozin on total heart failure events across the kidney function spectrum: Participant-level pooled analysis from the CANVAS Program and CREDENCE trialMuthiah Vaduganathan, Christopher P Cannon, Meg J Jardine, et al.
Journal of Hypertension|October 1, 2010
The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trialsSébastien Czernichow, Alberto Zanchetti, Fiona Turnbull, et al.
Journal of the American Heart Association|January 8, 2017
Mean Dietary Salt Intake in Urban and Rural Areas in India: A Population Survey of 1395 PersonsClaire Johnson, Sailesh Mohan, Kris Rogers, et al.
Circulation|June 27, 2018
Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney FunctionBrendon L Neuen, Toshiaki Ohkuma, Bruce Neal, et al.
BMJ (Clinical Research Ed.)|April 24, 2020
Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: modelling studyMatti Marklund, Gitanjali Singh, Raquel Greer, et al.
Kidney International|December 14, 2012
Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitusMuh Geot Wong, Vlado Perkovic, Mark Woodward, et al.
International Journal of Cardiology|June 23, 2020
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS programClare Arnott, Brendon L Neuen, Hiddo J L Heerspink, et al.
Frontiers in Nutrition|June 29, 2026
Dietary intake and sources of sodium and potassium, and salt-related knowledge, attitudes, and behaviours among rural adults in China: a cross-sectional studyBeike Wu, Jianwei Xu, Zhifang Li, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|August 14, 2018
Percentage of ingested sodium excreted in 24-hour urine collections: A systematic review and meta-analysisAaron M Lucko, Chelsea Doktorchik, Mark Woodward, et al.
American Heart Journal|June 5, 2017
Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)-A large-scale cluster randomized controlled trialBruce Neal, Maoyi Tian, Nicole Li, et al.
Pageof 49